This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations by Eun Sun Park: A Pioneer in PRPK-TPRKB Modulation
Introduction: Eun Sun Park is an innovative inventor based in Arlington, MA, known for his contributions in the field of molecular biology. With a focus on PRPK and TPRKB modulators, Park’s research is directed towards developing methods for identifying agents that can significantly impact medical treatments.
Latest Patents: Park holds a notable patent titled "PRPK-TPRKB modulators and uses thereof." This invention outlines methods for identifying agents that modulate PRPK, TPRKB, OSGEP, LAGE3, and their homologs. It also includes compositions of such agents that can be utilized in treating diseases, disorders, or conditions related to these proteins and their complexes.
Career Highlights: Eun Sun Park is an employee at Taiho Pharmaceutical Company Limited, where he continues to pursue innovative research and development in pharmaceuticals. His work is crucial for advancing therapeutic strategies.
Collaborations: Park collaborates with esteemed colleagues, including Henry Efrem Pelish and Astrid S Clarke. Their combined expertise fosters a dynamic research environment, enhancing the potential for impactful discoveries in their field.
Conclusion: Eun Sun Park's contributions to the understanding and modulation of PRPK and TPRKB are commendable. His patent and ongoing research efforts exemplify the innovative spirit necessary for advancing medical science. Through collaboration with skilled coworkers, he continues to push the boundaries of what is possible in pharmaceutical innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile